• Physiology

  • Events 

    October 18 - 22, 2015

    Tenth Cooley's Anemia Symposium

    Global experts explore the biology of globin gene regulation and fetal hemoglobin induction; stem cell transplant, gene therapy strategies, and gene editing; and clinical issues in thalassemia treatment and imaging.

  • Past Events

    Thursday, October 24, 2013 | 8:30 AM - 7:00 PM

    Seventh Annual Parkinson's Disease Therapeutics Conference

    Speakers: Charles H. Adler (Mayo Clinic Arizona / Arizona Parkinson's Disease Consortium), Raymond Bartus (RTBioconsultants, Inc.), Donald E. Frail (AstraZeneca PLC), Reina Fuji, VMD (Genentech Inc.), Kimberley S. Gannon (NeuroPhage Pharmaceuticals, Inc.), Kenneth Marek (Institute for Neurodegenerative Disorders), Mary Maral Mouradian (Rutgers - Robert Wood Johnson Medical School), Adrian Newman-Tancredi (Neurolixis, Inc.), Michael A. Schwarzschild (Massachusetts General Hospital), Eric Siemers (Eli Lilly and Company), Peggy Taylor (Covance Inc.)

    Explore emerging basic and translational research that impacts our understanding of Parkinson's Disease and its treatment.

    Monday, June 24, 2013 | 10:30 AM - 3:00 PM

    Translating Immunology Discoveries into Therapies: Inaugural Ross Prize in Molecular Medicine

    Speakers: Yasmine Belkaid (National Institute of Allergy and Infectious Diseases, NIH), Dan R. Littman (New York University School of Medicine), Alexander Rudensky (Memorial Sloan-Kettering Cancer Center)

    The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine.

    Tuesday, March 12, 2013 | 8:30 AM - 4:30 PM

    The Good Fat: Understanding Adipogenesis and Function of Brown Fat

    Speakers: Sheng Bi (Johns Hopkins University School of Medicine), Sheila Collins (Sanford-Burnham Medical Research Institute, Diabetes and Obesity Research Center), Abdul G. Dulloo (University of Fribourg), Vicente Gilsanz (Children's Hospital Los Angeles), Andrew C. Larner (Virginia Commonwealth University), David A. Price, Pfizer, Inc, Devanjan Sikder (Sanford-Burnham Medical Research Institute, Diabetes and Obesity Research Center), J. Enrique Silva (Tufts University School of Medicine), Bruce M Spiegelman (Dana-Farber Cancer Institute, Harvard Medical School), Anne-Ulrike Trendelenburg (Novartis Institutes for BioMedical Research, Yu-Hua Tseng (Joslin Diabetes Center, Harvard Medical School), Richard L. Veech (National Institute on Alcohol Abuse and Alcoholism/NIH)

    This conference will present recent research exploring adipogenesis focusing on brown adipose tissue, and will explore its implications in diet-induced obesity.

    June 26 - 27, 2012

    Inositol Phospholipid Signaling in Physiology and Disease

    Organizers: William G. Kerr (SUNY Upstate Medical University), Christina Mitchell (Monash University, Australia), and Christian Rommel (Intellikine)
    Keynote Speaker: Lewis C. Cantley (Harvard Medical School)

    Examine the role of Inositol Phospholipid (IP) signaling in cancer, metabolic, and inflammatory disease. This exploration of the specificity and interplay of diverse IP-modifying enzymes aims to identify novel approaches for therapeutic intervention.

  • Publications 


    The 12th OESO World Conference: Cancers of the Esophagus

    Edited by Robert Giuli (Deputy Director of OESO, Executive Director of the OESO Foundation, Paris, France) and Asad Umar (National Cancer Institute, Rockville, Maryland)

    This Annals volume presents a compilation of expert views on topics related to esophageal cancers presented at the World Organization for Specialized Studies on Diseases of the Esophagus 12th World Conference.

    Volume 1325


    The Year in Diabetes and Obesity

    Edited by Rexford S. Ahima (University of Pennsylvania, Philadelphia, Pennsylvania) and Alvin C. Powers (Vanderbilt University, Nashville, Tennessee)

    This Annals volume presents scholarly reviews by leading experts in diabetes and obesity research.


    Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents three meeting reports: (1) Probiotics, Prebiotics, and the Host Microbiome: the Science of Translation; (2) Capacity Building in Nutrition Science: Revisiting the Curricula for Medical Professionals; and (3) Circadian Clocks, Brain Function, and Development.

    Volume 1306


    Understanding Adipogenesis and Functions of Brown Fat

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals volume presents short reviews of the functions of brown adipose tissue and its potential therapeutic value in obesity management.

  • Webinar Archives

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at